BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 1497160)

  • 21. Follow-up Papanicolaou smear for cervical atypia: are we missing significant disease? A HARNET Study.
    Slawson DC; Bennett JH; Herman JM
    J Fam Pract; 1993 Mar; 36(3):289-93. PubMed ID: 8454975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States.
    Rahangdale L; Sarnquist C; Yavari A; Blumenthal P; Israelski D
    J Womens Health (Larchmt); 2010 Apr; 19(4):709-12. PubMed ID: 20201703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Situation analysis for management of abnormal Pap smears in the lower southern Thailand.
    Chichareon SB; Tassee S; Wootipoom V; Buhachat R; Harnprasertpong J
    Asian Pac J Cancer Prev; 2005; 6(3):286-94. PubMed ID: 16235988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervicography: adjunctive cervical cancer screening by primary care clinicians.
    Ferris DG; Payne P; Frisch LE; Milner FH; diPaola FM; Petry LJ
    J Fam Pract; 1993 Aug; 37(2):158-64. PubMed ID: 8336097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of cytological abnormalities within 24 months of a normal cervical smear in Soweto, South Africa.
    Adam Y; McIntyre JA; De Bruyn G
    S Afr Med J; 2012 Nov; 103(1):34-9. PubMed ID: 23237122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of abnormal Pap smears in rural family practice.
    Miller KS; Yunger J; Single N; Kunz J
    J Rural Health; 1996; 12(1):33-8. PubMed ID: 10157081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification, management, and tracking of abnormal Papanicolaou smears.
    Estrin HM
    J Am Coll Health; 1989 May; 37(6):283-7. PubMed ID: 2723261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 12-county program: screening of 34,318 women for cervical cancer in California, 1975-78.
    Schwarz PJ; Fasal E; Simmons ME
    Public Health Rep; 1981; 96(6):547-54. PubMed ID: 7302109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors Affecting Non-Histologically Proven Invasive Cancer of the Uterine Cervix that Had an Abnormal Pap Smear: Results of the CCS Program.
    Thipsanthiah K; Kamsa-Ard S; Musika W; Teemuangsai W; Hawlader MDH
    Asian Pac J Cancer Prev; 2023 Oct; 24(10):3429-3436. PubMed ID: 37898847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High prevalence of human papillomavirus and cervical intraepithelial neoplasia in a young Australian STD population.
    McKinnon KJ; Ford RM; Hunter JC
    Int J STD AIDS; 1991; 2(4):276-9. PubMed ID: 1655057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased frequency of abnormal Papanicolaou smears in adolescents.
    Silva CS; Souza MA; Angelo AG; Pavani R; Adad SJ; Murta EF
    Arch Gynecol Obstet; 2002 Jul; 266(3):154-6. PubMed ID: 12197555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of cytology-based cervical cancer screening in rural Cameroon.
    Robyr R; Nazeer S; Vassilakos P; Matute JC; Sando Z; Halle G; Mbakop A; Campana A
    Acta Cytol; 2002; 46(6):1110-6. PubMed ID: 12462091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of ASC-H terminology on the detection of HSILs in medically underserved California women.
    Howell LP; Gurusinghe S; Tabnak F
    Diagn Cytopathol; 2009 Feb; 37(2):103-10. PubMed ID: 19021201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal cervical cytology in sexually active adolescents.
    Russo JF; Jones DE
    J Adolesc Health Care; 1984 Oct; 5(4):269-71. PubMed ID: 6490482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a one-parameter flow analysis of cervical samples for gynecology cancer screening.
    Tsou KC; Pearson S; Atkinson BF; Giuntoli R; Mangan C
    Gynecol Oncol; 1983 Jun; 15(3):316-24. PubMed ID: 6190710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergency department pelvic examination and Pap testing: addressing patient misperceptions.
    Lyons MS; Lindsell CJ; Trott AT
    Acad Emerg Med; 2004 Apr; 11(4):405-8. PubMed ID: 15064218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pap smears: interpreting the new Bethesda terminology.
    Gore H; Shingleton HM
    J Surg Oncol; 1997 Feb; 64(2):95-7. PubMed ID: 9047243
    [No Abstract]   [Full Text] [Related]  

  • 39. Knowledge, attitude and practice of the pap smear as a screening procedure among nurses in a tertiary hospital in north eastern India.
    Thippeveeranna C; Mohan SS; Singh LR; Singh NN
    Asian Pac J Cancer Prev; 2013; 14(2):849-52. PubMed ID: 23621250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervical cytology in Greenland and occurrence of cervical carcinoma, carcinoma in situ, and dysplasia. Extent and impact of uncoordinated screening activity 1976-1985.
    Højgaard Nielsen N; Jensen H; Hansen PK
    Arctic Med Res; 1988 Oct; 47(4):179-88. PubMed ID: 3214508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.